Wolfe Research reiterated coverage on Abbott Labs with a new price target
$ABT
Biotechnology: Pharmaceutical Preparations
Health Care
Wolfe Research reiterated coverage of Abbott Labs with a rating of Underperform and set a new price target of $103.00 from $107.00 previously